Biogen Inc banner

Biogen Inc
LSE:0R1B

Watchlist Manager
Biogen Inc Logo
Biogen Inc
LSE:0R1B
Watchlist
Price: 214.54 USD 2.31% Market Closed
Market Cap: $31.3B

Wall St Price Targets

0R1B Price Targets Summary
Biogen Inc

Wall Street analysts forecast 0R1B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0R1B is 225.12 USD with a low forecast of 151.45 USD and a high forecast of 314.9 USD.

Lowest Forecast
Price Target
151.45 USD
29% Downside
Average Forecast
Price Target
225.12 USD
5% Upside
Highest Forecast
Price Target
314.9 USD
47% Upside
Biogen Inc Competitors:
Price Targets
NYXH
Nyxoah SA
236% Upside
8961
Mori Trust Sogo Reit Inc
10% Upside

Revenue
Forecast

5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.

Gross Profit
Forecast

3% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
3% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 3%.

Operating Income
Forecast

2% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
2% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.

Pre-Tax Income
Forecast

-1% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
-1% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 27%.

Net Income
Forecast

-1% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
-1% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0R1B's stock price target?
Price Target
225.12 USD

According to Wall Street analysts, the average 1-year price target for 0R1B is 225.12 USD with a low forecast of 151.45 USD and a high forecast of 314.9 USD.

What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.

What is the Gross Profit forecast for Biogen Inc?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 3%.

What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.

What is the Pre-Tax Income forecast for Biogen Inc?
Projected CAGR
27%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 27%.

What is the Net Income forecast for Biogen Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett